Raleigh Capital Management Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1911726
CARY, NC
Position in VRTX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$59,110
-$2,065 QoQ
Shares Held
119
-13.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,518
of 1,735 holders
Holding Since
Dec 2021
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Raleigh Capital Management Inc. holds $110,609 across 3 Biotechnology names. VRTX ranks #1 (53.4% of the industry book) .
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,110 | 119 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $61,175 | 137 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $54,403 | 120 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $49,346 | 126 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $58,321 | 131 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $229,319 | 473 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $95,037 | 236 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $115,804 | 249 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $115,773 | 247 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $88,618 | 212 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $20,343 | 50 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $6,954 | 20 | Shares | Sole | 2023-12-08 | |
| 2023-06-30 | $6,686 | 19 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $5,986 | 19 | Shares | Sole | 2023-05-22 | |
| 2021-12-31 | $878 | 4 | Shares | Sole | 2022-02-16 | |
| No filing history on record for this holder in this stock. | ||||||